Dror Ortho-Design, INC. (DROR) — SEC Filings

Overview

Dror Ortho-Design, INC. (DROR) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a S-1/A filed on Apr 1, 2026: Dror Ortho-Design, Inc. (DROR) is offering up to 3,636,364 shares of common stock at an assumed public offering price of $4.13 per share, alongside prefunded warrants and underwriter warrants. The company, currently trading on the OTC Pink Limited Market under 'DROR' at $0.0052 per share as of March

Sentiment Summary

Across 24 filings, the sentiment breakdown is: 3 bearish, 20 neutral, 1 mixed. The dominant filing sentiment for Dror Ortho-Design, INC. is neutral.

Filing Type Overview

Dror Ortho-Design, INC. (DROR) has filed 4 S-1/A, 7 8-K, 6 10-Q, 2 S-1, 1 DEF 14A, 2 10-K, 1 10-K/A, 1 SC 13G/A with the SEC between Jan 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (24)

• Dror Ortho-Design Targets Nasdaq with $4.13 IPO, 1-for-550 Reverse Split — S-1/A · Apr 1, 2026 Risk: high
  Dror Ortho-Design, Inc. (DROR) is offering up to 3,636,364 shares of common stock at an assumed public offering price of $4.13 per share, alongside prefunded wa
• Dror Ortho-Design Files 8-K with Material Agreement — 8-K · Dec 8, 2025 Risk: medium
  Dror Ortho-Design, Inc. entered into a Material Definitive Agreement on December 2, 2025. The company also reported on Unregistered Sales of Equity Securities a
• Dror Ortho-Design Narrows Losses Amidst Cash Burn, Debt Surge — 10-Q · Nov 18, 2025 Risk: high
  Dror Ortho-Design, Inc. (DROR) reported a net loss of $653,528 for the three months ended September 30, 2025, a significant improvement from the $1,826,935 net
• Dror Ortho-Design's Losses Narrow, Cash Dwindles Amid R&D Cuts — 10-Q · Aug 14, 2025 Risk: high
  Dror Ortho-Design, Inc. (DROR) reported a net loss of $759,338 for the three months ended June 30, 2025, a significant improvement from the $1,506,790 net loss
• Dror Ortho-Design Files 8-K: Material Agreement, Equity Sales — 8-K · Jul 23, 2025 Risk: medium
  Dror Ortho-Design, Inc. filed an 8-K on July 23, 2025, reporting on events that occurred on July 17, 2025. The filing indicates an entry into a material definit
• Dror Ortho-Design Amends S-1 for IPO Launch — S-1/A · Jul 14, 2025 Risk: medium
  Dror Ortho-Design, Inc. (DROR) filed an S-1/A on July 14, 2025, for its initial public offering, indicating its intent to commence a public sale of securities a
• Dror Ortho-Design Files 8-K on Shareholder Vote Matters — 8-K · Jun 25, 2025 Risk: low
  Dror Ortho-Design, Inc. filed an 8-K on June 25, 2025, reporting a submission of matters to a vote of security holders. The filing date for this report is June
• Dror Ortho-Design, Inc. Files 8-K with Material Agreement — 8-K · Jun 18, 2025 Risk: medium
  On June 16, 2025, Dror Ortho-Design, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and
• Dror Ortho-Design Files 8-K — 8-K · Jun 10, 2025 Risk: low
  Dror Ortho-Design, Inc. filed an 8-K on June 10, 2025, reporting an event under 'Other Events'. The filing does not contain specific financial figures or detail
• Dror Ortho-Design Files 8-K with Key Agreements — 8-K · Jun 5, 2025 Risk: medium
  Dror Ortho-Design, Inc. filed an 8-K on June 5, 2025, reporting a material definitive agreement, unregistered sales of equity securities, and financial statemen
• Dror Ortho-Design Files S-1 for Public Debut, Eyes Dental Market — S-1 · May 28, 2025 Risk: medium
  Dror Ortho-Design, Inc. (DROR) filed an S-1 registration statement on May 28, 2025, indicating its intent to go public. The company, incorporated in Delaware wi
• Dror Ortho-Design Files Definitive Proxy Statement — DEF 14A · May 21, 2025 Risk: low
  Dror Ortho-Design, Inc. filed its Definitive Proxy Statement (DEF 14A) on May 21, 2025, for the fiscal year ending December 31, 2025. The filing provides inform
• Dror Ortho-Design, Inc. Files Q1 2025 10-Q — 10-Q · May 15, 2025 Risk: low
  Dror Ortho-Design, Inc. filed its quarterly report on Form 10-Q for the period ended March 31, 2025. The company, formerly known as NOVINT TECHNOLOGIES INC, is
• Dror Ortho-Design Files 2024 10-K — 10-K · Feb 19, 2025 Risk: low
  Dror Ortho-Design, Inc. filed its annual report on Form 10-K for the fiscal year ended December 31, 2024. The company, formerly known as NOVINT TECHNOLOGIES INC
• Dror Ortho-Design Files Q3 2024 10-Q — 10-Q · Nov 14, 2024 Risk: low
  Dror Ortho-Design, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2024. The company, formerly known as NOVINT TECHNOLOGIES INC,
• Dror Ortho-Design Files Q2 2024 10-Q — 10-Q · Aug 14, 2024 Risk: low
  Dror Ortho-Design, Inc. filed its 10-Q for the quarterly period ended June 30, 2024. The company, formerly known as NOVINT TECHNOLOGIES INC, is incorporated in
• Dror Ortho-Design Files S-1/A Amendment — S-1/A · Jun 5, 2024 Risk: medium
  Dror Ortho-Design, Inc. filed an S-1/A amendment on June 5, 2024, for its registration statement (No. 333-276981). The company, formerly Novint Technologies Inc
• Dror Ortho-Design Files Q1 2024 10-Q — 10-Q · May 20, 2024 Risk: low
  Dror Ortho-Design, Inc. filed its quarterly report on Form 10-Q for the period ending March 31, 2024. The company, formerly known as NOVINT TECHNOLOGIES INC, is
• Dror Ortho-Design, Inc. Files Amendment No. 1 to Form 10-K for Fiscal Year Ended Dec 31, 2023 — 10-K/A · Apr 25, 2024 Risk: low
  Dror Ortho-Design, Inc. (DROR) filed a Amended Annual Report (10-K/A) with the SEC on April 25, 2024. Dror Ortho-Design, Inc. filed an amendment (10-K/A) to its
• Dror Ortho-Design, Inc. Files Amendment No. 1 to S-1 Registration Statement — S-1/A · Apr 17, 2024 Risk: low
  Dror Ortho-Design, Inc. (DROR) filed a Amended IPO Registration (S-1/A) with the SEC on April 17, 2024. Dror Ortho-Design, Inc. filed an S-1/A (Amendment No. 1)
• Dror Ortho-Design, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Apr 1, 2024 Risk: low
  Dror Ortho-Design, Inc. (DROR) filed a Annual Report (10-K) with the SEC on April 1, 2024. Dror Ortho-Design, Inc. filed its annual report on Form 10-K for the
• Dror Ortho-Design, Inc. Files S-1 Registration Statement — S-1 · Feb 9, 2024 Risk: medium
  Dror Ortho-Design, Inc. (DROR) filed a IPO Registration (S-1) with the SEC on February 9, 2024. Dror Ortho-Design, Inc. filed an S-1 registration statement on F
• Alpha Capital Amends Dror Ortho-Design Stake on Dec 31, 2023 — SC 13G/A · Jan 10, 2024
  Alpha Capital Anstalt, a Liechtenstein-based investment firm, filed an Amendment No. 3 to Schedule 13G on January 10, 2024, indicating a change in their ownersh
• Dror Ortho-Design 8-K: Governance, Rights, Bylaw Changes Reported — 8-K · Jan 4, 2024
  Dror Ortho-Design, Inc. filed an 8-K on January 4, 2024, reporting an event that occurred on December 29, 2023. This filing indicates potential material modific

Risk Profile

Risk Assessment: Of DROR's 22 recent filings, 3 were flagged as high-risk, 8 as medium-risk, and 11 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from Dror Ortho-Design, INC.'s most recent 10-Q filing (Nov 18, 2025):

• Revenue: $0
• Net Income: -$653,528
• EPS: -$0.00
• Debt-to-Equity: N/A
• Cash Position: $240,362
• Operating Margin: N/A
• Total Assets: $271,218
• Total Debt: $2,589,031

Key Executives

• Eliyahu (Lee) Haddad
• Rick A. Werner, Esq.
• Lawrence Metelitsa, Esq.
• Rick Werner
• Lawrence Metelitsa

Industry Context

The clear aligner market is highly competitive, dominated by established players like Align Technology (Invisalign). Dror Ortho-Design aims to differentiate its ZSmile platform through AI-driven personalization and a focus on discreet, less painful nighttime correction. However, gaining market share against entrenched competitors with significant brand recognition and distribution networks will be challenging.

Top Tags

IPO (4) · material-agreement (4) · equity-sale (4) · SEC Filing (4) · 10-Q (4) · quarterly-report (4) · Dror Ortho-Design (4) · Orthodontics (3) · dental-equipment (3) · Medical Devices (2)

Key Numbers

• Assumed public offering price per share: $4.13 — Used for common stock and prefunded warrants
• Shares of Common Stock offered: 3,636,364 — Initial offering amount
• Expected reverse stock split ratio: 1-for-550 — To be effected prior to or upon effectiveness of registration
• Shares of Common Stock outstanding as of March 31, 2026: 976,997,116 — Before reverse stock split adjustment
• Last reported sales price for Common Stock on OTC Pink: $0.0052 — As of March 31, 2026
• Underwriter Warrants shares: 254,545 — Number of shares underlying underwriter warrants
• Underwriter Warrants exercise price: $5.1625 — 125% of the offering price per share
• Over-allotment option shares: 545,455 — Additional shares underwriters can purchase
• Filing date of S-1/A: 2026-04-01 — Amendment No. 3 filed
• Date of stockholder approval for reverse stock split: 2025-06-23 — Special meeting approval date
• Accumulated Deficit: $21.5M — Increased from $19.5M at Dec 31, 2024, highlighting ongoing losses.
• Net Loss (9 months): $1.99M — Reduced from $4.64M in the prior year, showing some operational efficiency.
• Cash Balance: $240K — Decreased from $549K at Dec 31, 2024, indicating significant cash burn.
• Total Current Liabilities: $2.42M — Increased from $907K at Dec 31, 2024, primarily due to new debt instruments.
• Proceeds from Convertible Notes: $1.1M — Raised during the nine months ended Sep 30, 2025, crucial for operations.

Forward-Looking Statements

• {"claim":"Dror Ortho-Design, Inc. will complete its IPO within the next 6-12 months.","entity":"Dror Ortho-Design, Inc.","targetDate":"2025-02-09","confidence":"medium"}
• {"claim":"The company will face scrutiny regarding its transition from 'Novint Technologies Inc.' and its current business model in 'Computer Peripheral Equipment'.","entity":"Dror Ortho-Design, Inc.","targetDate":"2024-08-09","confidence":"high"}

Related Companies

ALGN

Frequently Asked Questions